Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
117-hr-7032117th Congress
Increasing Transparency in Generic Drug Applications Act of 2022
Sponsored By: Representative Kuster, Ann M. [D-NH-2]
Unknown
Summary
Increasing Transparency in Generic Drug Applications Act of 2022 This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Kuster, Ann M. [D-NH-2]
NH • D
Cosponsors
Rep. Schrier, Kim [D-WA-8]
WA • D
Sponsored 4/1/2022
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov